Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome by Low Dose Cytosine Arabinoside

H.J. Weh; R. Zschaber; A. von Paleske; D. K. Hossfeld

doi:10.1007/978-3-642-70385-0_14

ScienceGate Book Chapters

JOURNAL ARTICLE

Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome by Low Dose Cytosine Arabinoside

H.J. Weh R. Zschaber A. von Paleske D. K. Hossfeld

Year: 1985 Journal: Hämatologie und Bluttransfusion Vol: 29 Pages: 60-62 Publisher: Springer Nature

DOI: 10.1007/978-3-642-70385-0_14

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Myeloid leukemia Cytarabine Chemotherapy Internal medicine Myelodysplastic syndromes Bone marrow Gastroenterology Cytosine Myeloid Leukemia Oncology Chemistry

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.13

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Acute Myeloid Leukemia Research

Health Sciences → Medicine → Hematology

Acute Lymphoblastic Leukemia research

Health Sciences → Medicine → Public Health, Environmental and Occupational Health

Retinoids in leukemia and cellular processes

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome by Low Dose Cytosine Arabinoside

Metrics

Citation History

Topics

Related Documents

Low Dose Cytosine Arabinoside Therapy in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Low-dose cytosine arabinoside in the treatment of acute myeloid leukemia

Low-Dose Cytosine Arabinoside in Patients with Acute Myeloblastic Leukemia and Myelodysplastic Syndrome

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia